Mohajeri, M H <br/><br/>
Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis.  [electronic resource] 

 -  Human gene therapy  Jul 1999 
 - 1853-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/10430349950017536  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyotrophic Lateral Sclerosis--therapy<br/>Animals<br/>Cell Transplantation<br/>Disease Models, Animal<br/>Disease Progression<br/>Genetic Therapy<br/>Genetic Vectors<br/>Glial Cell Line-Derived Neurotrophic Factor<br/>Humans<br/>Mice<br/>Motor Neurons--physiology<br/>Muscle, Skeletal--cytology<br/>Nerve Growth Factors<br/>Nerve Tissue Proteins--genetics<br/>Retroviridae--genetics<br/>Transduction, Genetic<br/>beta-Galactosidase--genetics